The overall goal of this project is to elucidate the molecular basis for how protein acetyltransferases (PATs) recognize and acetylate their cognate protein substrates and how this process to modulated by protein cofactors and posttranslational modification. The most well studied protein acetyltransferases are the histone acetyltransferases (HATs) that acetylate histone, and in some cases other proteins, to mediate several different transcription-mediated biological processes including cell cycle progression, dosage compensation and hormone signaling;and aberrant HAT function has also been correlated with human disease, including leukemic translocations, solid tumors and metabolic disorders. HATs fall into at least four families based on sequence conservation, Gcn5/PCAF, MYST, p300/CBP and Rtt109. Over the last two funding periods, my laboratory reported on the structure and chemistry of these enzymes revealing that despite the sequence divergence between the HAT families, they contain a structurally related core region to mediate Ac-CoA cofactor and protein substrate binding but structurally divergent core flanking regions to mediated different modes of catalysis and other biological properties. Most recently, we have found that many HATs are regulated by autoacetylation and have identified HAT-selective inhibitors that may have therapeutic applications. More recent studies by other laboratories have also uncovered that over 2000 human proteins are acetylated, extending to many different types of proteins such as kinases and RNA processing factors and extending beyond nuclear processes such as vesicular trafficking and metabolism. These recent findings suggest that protein acetylation is just as important a posttranslational modification in signal transduction as protein phosphorylation and that acetyltransferases are just as important therapeutic targets as protein kinases. Despite our current understanding of HATs, several important questions about protein acetylation remain. These questions include, (1) How are PATs regulated by autoacetylation, (2) How are PATs regulated by associated cofactor proteins, (3) How do HATs differ from other PATs and (4) How do PATs recognize their cognate substrates. In this proposal we will study the Rtt109 HAT, the NATA N-amino protein acetyltransferase and the aTAT1/MEC-17 tubulin acetyltransferase as model systems to answer these mechanistic questions that will have important implications for understanding the biology of protein acetylation and for the development of potent and selective protein acetyltransferase inhibitors with possible therapeutic applications.
The Specific Aims of the proposal are (1) Structure/Function studies of the Rtt109 histone acetyltransferase, (2) Structure/Function studies of the NATA N-amino protein acetyltransferase (NAT), and (3) Structure/Function of the aTAT1/MEC-17 a-tubulin acetyltransferase.

Public Health Relevance

Protein Acetyltransferase (PAT) enzymes play key roles in regulating many biological processes and aberrant PAT function has been correlated with several human diseases, including leukemic translocations, solid tumors and metabolic disorders. The overall goal of this project is to elucidate the molecular basis for how PAT enzymes recognize and acetylate their cognate protein substrates and how this process is modulated by protein cofactors and posttranslational modification. The yeast Rtt109 histone acetyltransferase, the human N- amino acetyltransferase complex NATA and the alpha -tubulin acetyltransferase alpha-TAT/MEC-17 will be used as model systems. These studies will provide information to aid in the design small molecule drugs to treat PAT- associated diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
2R01GM060293-13
Application #
8301928
Study Section
Macromolecular Structure and Function C Study Section (MSFC)
Program Officer
Preusch, Peter C
Project Start
2000-01-01
Project End
2016-11-30
Budget Start
2013-01-01
Budget End
2013-11-30
Support Year
13
Fiscal Year
2013
Total Cost
$392,322
Indirect Cost
$164,228
Name
Wistar Institute
Department
Type
DUNS #
075524595
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Maksimoska, Jasna; Segura-Peña, Dario; Cole, Philip A et al. (2014) Structure of the p300 histone acetyltransferase bound to acetyl-coenzyme A and its analogues. Biochemistry 53:3415-22
Zhang, Xinlei; Ouyang, Sisheng; Kong, Xiangqian et al. (2014) Catalytic mechanism of histone acetyltransferase p300: from the proton transfer to acetylation reaction. J Phys Chem B 118:2009-19
Marmorstein, Ronen; Zhou, Ming-Ming (2014) Writers and readers of histone acetylation: structure, mechanism, and inhibition. Cold Spring Harb Perspect Biol 6:a018762
Liszczak, Glen; Goldberg, Jacob M; Foyn, Havard et al. (2013) Molecular basis for N-terminal acetylation by the heterodimeric NatA complex. Nat Struct Mol Biol 20:1098-105
Friedmann, David R; Marmorstein, Ronen (2013) Structure and mechanism of non-histone protein acetyltransferase enzymes. FEBS J 280:5570-81
Cohen, Todd J; Friedmann, Dave; Hwang, Andrew W et al. (2013) The microtubule-associated tau protein has intrinsic acetyltransferase activity. Nat Struct Mol Biol 20:756-62
Abshiru, Nebiyu; Ippersiel, Kevin; Tang, Yong et al. (2013) Chaperone-mediated acetylation of histones by Rtt109 identified by quantitative proteomics. J Proteomics 81:80-90
Liszczak, Glen; Marmorstein, Ronen (2013) Implications for the evolution of eukaryotic amino-terminal acetyltransferase (NAT) enzymes from the structure of an archaeal ortholog. Proc Natl Acad Sci U S A 110:14652-7
Yuan, Hua; Marmorstein, Ronen (2013) Histone acetyltransferases: Rising ancient counterparts to protein kinases. Biopolymers 99:98-111
Pan, Min; Yuan, Hua; Brent, Michael et al. (2012) SIRT1 contains N- and C-terminal regions that potentiate deacetylase activity. J Biol Chem 287:2468-76

Showing the most recent 10 out of 22 publications